Cresco Labs Inc.

General ticker "CRLBF" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $313.5M (TTM average)

Cresco Labs Inc. follows the US Stock Market performance with the rate: 40.6%.

Estimated limits based on current volatility of 4.6%: low 0.81$, high 0.89$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.54$, 1.43$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.50$, 1.31$]

Financial Metrics affecting the CRLBF estimates:

  • Positive: with PPE of -4.2 at the end of fiscal year the price was very low
  • Positive: 7.86 < Operating profit margin, % of 14.81
  • Positive: Operating cash flow per share per price, % of 43.81 > 13.24
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
  • Negative: negative Net income
  • Positive: -14.38 < Investing cash flow per share per price, % of -8.34

Similar symbols

Short-term CRLBF quotes

Long-term CRLBF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $842.68MM $770.88MM $724.34MM
Operating Expenses $926.98MM $858.71MM $617.05MM
Operating Income $-84.30MM $-87.82MM $107.29MM
Non-Operating Income $-42.61MM $-59.08MM $-117.91MM
Interest Expense $58.52MM $63.24MM $58.90MM
Income(Loss) $-126.91MM $-146.90MM $-10.62MM
Taxes $88.94MM $32.95MM $49.87MM
Profit(Loss)* $-212.05MM $-175.52MM $-74.44MM
Stockholders Equity $627.04MM $505.69MM $474.85MM
Assets $1,583.69MM $1,358.47MM $1,355.36MM
Operating Cash Flow $18.74MM $58.56MM $132.48MM
Capital expenditure $86.13MM $57.88MM $23.49MM
Investing Cash Flow $-36.58MM $-44.59MM $-25.23MM
Financing Cash Flow $-86.64MM $-26.91MM $-71.48MM
Earnings Per Share** $-0.71 $-0.54 $-0.22

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.